ASHLEY POWELL: Open Payments
NPI 1194275321 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$704 in 32 payments from 14 companies in 2025. Trend: 2023 $579 · 2024 $539 · 2025 $704
Food & beverage: $704
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $195 |
| ARGENX US, INC. | 5 | $104 |
| Neurocrine BioSciences, Inc. | 4 | $88 |
| JAZZ PHARMACEUTICALS INC. | 2 | $54 |
| Amgen Inc. | 2 | $43 |
| UCB, Inc. | 2 | $41 |
| ACADIA Pharmaceuticals Inc | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| Alexion Pharmaceuticals, Inc. | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
Products named: QULIPTA, INGREZZA, VYALEV, XYWAV, UPLIZNA, Briviact, NUPLAZID, UBRELVY.
Industry payments across AL — which companies pay providers there.
